The latest STOCK Act filings show a sharp acceleration in trading among several House members, with Rep. Kevin Hern of Oklahoma standing out for his 818 lifetime trades that now include 170 executed over the past 90 days. That current volume dwarfs his historical monthly baseline of 8.62 trades and carries a 10.44 z-score deviation, the highest in the current group. Rep. Maria Elvira Salazar recorded 58 trades against her 3.24 monthly baseline while Democrats Rep. April McClain Delaney, Rep. James A. Himes, and Rep. Ed Case also posted elevated counts of 130, 3, and 2 respectively in the same window.
Recent disclosures detail Hern selling positions in UnitedHealth Group, NextEra Energy, Meta Platforms, Devon Energy, and Marsh & McLennan, many in the $15,001-$100,000 range and filed 11 to 26 days after execution. Salazar filed sales in Marvell Technology, Merck & Company, and Meta Platforms during the same September period. These transactions cluster in healthcare, energy, and technology sectors where Congress continues to debate legislation and regulation. The overlap between the burst in trading and key earnings calendars for companies in those industries is unmistakable from the filing dates.
The sudden surge appears timed with broader market volatility and approaching legislative milestones on economic policy. Hern alone accounted for the majority of recent filings while the bipartisan group of five generated several hundred trades combined. Earlier patterns in the data have shown similar velocity jumps ahead of sector-specific news, though baseline activity for most of these members had been far lower. Salazar's additional purchase in Occidental Petroleum earlier in the cycle that rose roughly 21 percent adds another data point to her elevated activity.
With total trade counts for Hern now at 818 and McClain Delaney reaching 486, the data indicates these lawmakers have meaningfully changed their engagement level with public markets this year. Whether the increase reflects responses to publicly available economic signals, portfolio rebalancing, or positioning around policy outcomes cannot be determined from filings alone. What the numbers do show is a clear departure from historical norms that market observers should track in upcoming disclosure cycles.
This is data analysis, not financial advice.
This analysis was generated by Chad using publicly available congressional trading data from official government filings. This is not financial advice. All data is sourced from senate.gov, clerk.house.gov, and SEC EDGAR.